Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by MustangSalleyon Apr 08, 2021 4:52pm
138 Views
Post# 32958751

RE:RE:RE:RE:RE:RE:Presentation

RE:RE:RE:RE:RE:RE:Presentation

Redbaron2211 wrote: Seems pretty involved for most shareholders I would call it an unlikely option especially at this juncture when the important information is held up in NDA's.  If I don't like management I move on.  Most investors/institutions I talk with are happy with Philip and optimistic so it seems there are obvious inconsistencies among those that hold large portions of the company.   I guess the only way to find out would be a vote.  Re AGM I was referring to the chance they are bought out. 


 

Red ,

The best thing that could be is a buyout before AGM but you are dreaming . You know why ? Because TOLEIKIS has no intention of selling this now. He wants to milk this as long as he can and keep contriol over it .  There is nobody to keep him to account , the board is sleepy that's the way he likes it . Ask him why Medtronics has not made an offer or done a deal yet ? Listen to his reasons why? Then in two years time you will reflect back on these posts but share price will be maybe $2 if your lucky but with a float of 500 to 600 million . Red you are only getting answers that keeps you in line . 


Ask Toleikis what the sentiment is with all the big shareholders ?  You'll get your answer. Hope is not a thesis for an investment  Red .

Ask Dominic he speaks more honestly than Toleikis and his partner in crime Matthews. Ask him what's going on with AGM ? Ask him what other investors are inquiring about AGM. Follow the smoke Red.

Ms Sally 


 

<< Previous
Bullboard Posts
Next >>